236 related articles for article (PubMed ID: 28229823)
21. Anti-Ro/SS-A and anti-La/SS-B antibodies associated with cardiac involvement in childhood systemic lupus erythematosus.
Oshiro AC; Derbes SJ; Stopa AR; Gedalia A
Ann Rheum Dis; 1997 Apr; 56(4):272-4. PubMed ID: 9166002
[TBL] [Abstract][Full Text] [Related]
22. Systemic lupus erythematosus activity and beta two microglobulin levels.
Skare TL; Ferri K; Santos MA
Sao Paulo Med J; 2014; 132(4):239-42. PubMed ID: 25055070
[TBL] [Abstract][Full Text] [Related]
23. Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients.
Houman MH; Smiti-Khanfir M; Ben Ghorbell I; Miled M
Lupus; 2004; 13(3):204-11. PubMed ID: 15119551
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease.
Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M
Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies to C-reactive protein in incomplete lupus and systemic lupus erythematosus.
Jung JY; Koh BR; Kim HA; Jeon JY; Suh CH
J Investig Med; 2014 Aug; 62(6):890-3. PubMed ID: 24896736
[TBL] [Abstract][Full Text] [Related]
26. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
[TBL] [Abstract][Full Text] [Related]
27. Serum human epididymis protein 4 is a predictor for developing nephritis in patients with systemic lupus erythematosus: A prospective cohort study.
Ren Y; Xie J; Lin F; Luo W; Zhang Z; Mao P; Zhong R; Liang Y; Yang Z
Int Immunopharmacol; 2018 Jul; 60():189-193. PubMed ID: 29747124
[TBL] [Abstract][Full Text] [Related]
28. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
Ramos-Casals M; Campoamor MT; Chamorro A; Salvador G; Segura S; Botero JC; Yagüe J; Cervera R; Ingelmo M; Font J
Lupus; 2004; 13(10):777-83. PubMed ID: 15540510
[TBL] [Abstract][Full Text] [Related]
29. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
30. Systemic lupus erythematosus presenting with cardiac symptoms.
Chen PY; Chang CH; Hsu CC; Liao YY; Chen KT
Am J Emerg Med; 2014 Sep; 32(9):1117-9. PubMed ID: 25082598
[TBL] [Abstract][Full Text] [Related]
31. Pediatric systemic lupus erythematosus. Retrospective analysis of clinico-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score.
Nazri SKSM; Wong KK; Hamid WZWA
Saudi Med J; 2018 Jun; 39(6):627-631. PubMed ID: 29915860
[TBL] [Abstract][Full Text] [Related]
32. Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes.
Pluchinotta FR; Schiavo B; Vittadello F; Martini G; Perilongo G; Zulian F
Lupus; 2007; 16(8):550-5. PubMed ID: 17711887
[TBL] [Abstract][Full Text] [Related]
33. Peripheral arterial disease in patients with systemic lupus erythematosus: a prospective controlled study.
Hassan AA; Habib HM; Eissa AA
Int J Rheum Dis; 2013 Jun; 16(3):319-24. PubMed ID: 23981754
[TBL] [Abstract][Full Text] [Related]
34. Serum ferritin as a serologic marker of activity in systemic lupus erythematosus.
Lim MK; Lee CK; Ju YS; Cho YS; Lee MS; Yoo B; Moon HB
Rheumatol Int; 2001 Apr; 20(3):89-93. PubMed ID: 11354563
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of platelet count in SLE patients.
Abdel Galil SM; Edrees AM; Ajeeb AK; Aldoobi GS; El-Boshy M; Hussain W
Platelets; 2017 Mar; 28(2):203-207. PubMed ID: 27590999
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of systemic lupus erythematosus in a sample of the Egyptian population: a retrospective cohort of 1109 patients from a single center.
El Hadidi KT; Medhat BM; Abdel Baki NM; Abdel Kafy H; Abdelrahaman W; Yousri AY; Attia DH; Eissa M; El Dessouki D; Elgazzar I; Elgengehy FT; El Ghobashy N; El Hadary H; El Mardenly G; El Naggar H; El Nahas AM; El Refai RM; El Rwiny HA; Elsman RM; Galal M; Ghoniem S; Maged LA; Sally SM; Naji H; Saad S; Shaaban M; Sharaf M; Sobhy N; Soliman RM; El Hadidi TS
Lupus; 2018 May; 27(6):1030-1038. PubMed ID: 29431056
[TBL] [Abstract][Full Text] [Related]
37. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
38. Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients.
Choi JH; Park DJ; Kang JH; Yim YR; Lee KE; Lee JW; Wen L; Kim TJ; Park YW; Lee JK; Lee SS
Lupus; 2015 Oct; 24(12):1342-9. PubMed ID: 26085595
[TBL] [Abstract][Full Text] [Related]
39. A comparison of three anti-double stranded DNA antibody assays on sera from SLE and other diseases.
Clarke MC; Carr R; Burdash NM; Chen ZY; Ainsworth SK
Diagn Immunol; 1986; 4(6):288-93. PubMed ID: 3545632
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary manifestations in systemic lupus erythematosus: association with disease activity.
Alamoudi OS; Attar SM
Respirology; 2015 Apr; 20(3):474-80. PubMed ID: 25639532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
